Calcium in PDB 1de4: Hemochromatosis Protein Hfe Complexed with Transferrin Receptor
Protein crystallography data
The structure of Hemochromatosis Protein Hfe Complexed with Transferrin Receptor, PDB code: 1de4
was solved by
M.J.Bennett,
J.A.Lebron,
P.J.Bjorkman,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
30.00 /
2.80
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
110.400,
144.400,
327.100,
90.00,
93.60,
90.00
|
R / Rfree (%)
|
23.1 /
26.5
|
Calcium Binding Sites:
The binding sites of Calcium atom in the Hemochromatosis Protein Hfe Complexed with Transferrin Receptor
(pdb code 1de4). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 3 binding sites of Calcium where determined in the
Hemochromatosis Protein Hfe Complexed with Transferrin Receptor, PDB code: 1de4:
Jump to Calcium binding site number:
1;
2;
3;
Calcium binding site 1 out
of 3 in 1de4
Go back to
Calcium Binding Sites List in 1de4
Calcium binding site 1 out
of 3 in the Hemochromatosis Protein Hfe Complexed with Transferrin Receptor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Hemochromatosis Protein Hfe Complexed with Transferrin Receptor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca801
b:47.7
occ:1.00
|
OE1
|
C:GLU465
|
2.3
|
41.8
|
1.0
|
OE1
|
C:GLU468
|
2.3
|
45.0
|
1.0
|
O
|
C:PHE313
|
2.4
|
48.2
|
1.0
|
O
|
C:THR310
|
2.4
|
59.4
|
1.0
|
OE2
|
C:GLU465
|
2.7
|
44.5
|
1.0
|
OG1
|
C:THR310
|
2.8
|
44.6
|
1.0
|
CD
|
C:GLU465
|
2.8
|
56.0
|
1.0
|
C
|
C:THR310
|
3.4
|
51.3
|
1.0
|
CB
|
C:THR310
|
3.4
|
38.9
|
1.0
|
CD
|
C:GLU468
|
3.5
|
54.4
|
1.0
|
C
|
C:PHE313
|
3.5
|
41.1
|
1.0
|
O
|
C:ASP307
|
3.9
|
50.0
|
1.0
|
CA
|
C:THR310
|
4.0
|
49.0
|
1.0
|
OE2
|
C:GLU468
|
4.0
|
62.2
|
1.0
|
N
|
C:PHE313
|
4.1
|
36.4
|
1.0
|
OG
|
C:SER315
|
4.3
|
31.1
|
1.0
|
N
|
C:ASP307
|
4.3
|
53.4
|
1.0
|
CG
|
C:GLU465
|
4.3
|
45.2
|
1.0
|
CA
|
C:PRO314
|
4.3
|
31.4
|
1.0
|
CB
|
C:ASP307
|
4.3
|
52.0
|
1.0
|
N
|
C:PRO314
|
4.4
|
37.6
|
1.0
|
N
|
C:PRO311
|
4.4
|
52.9
|
1.0
|
N
|
C:SER315
|
4.5
|
24.1
|
1.0
|
CA
|
C:PHE313
|
4.5
|
37.6
|
1.0
|
N
|
C:GLY312
|
4.5
|
44.8
|
1.0
|
C
|
C:PRO314
|
4.6
|
37.2
|
1.0
|
CA
|
C:PRO311
|
4.7
|
49.7
|
1.0
|
N
|
C:THR310
|
4.7
|
46.5
|
1.0
|
CG
|
C:GLU468
|
4.7
|
54.3
|
1.0
|
CA
|
C:ASP307
|
4.8
|
50.5
|
1.0
|
CG2
|
C:THR310
|
4.8
|
42.2
|
1.0
|
C
|
C:ASP307
|
4.8
|
49.6
|
1.0
|
C
|
C:PRO311
|
4.9
|
44.0
|
1.0
|
CA
|
C:GLU465
|
4.9
|
47.1
|
1.0
|
CB
|
C:GLU468
|
4.9
|
41.7
|
1.0
|
|
Calcium binding site 2 out
of 3 in 1de4
Go back to
Calcium Binding Sites List in 1de4
Calcium binding site 2 out
of 3 in the Hemochromatosis Protein Hfe Complexed with Transferrin Receptor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Hemochromatosis Protein Hfe Complexed with Transferrin Receptor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Ca802
b:45.0
occ:1.00
|
OE1
|
F:GLU465
|
2.2
|
39.7
|
1.0
|
O
|
F:PHE313
|
2.4
|
40.1
|
1.0
|
O
|
F:THR310
|
2.4
|
51.6
|
1.0
|
OE1
|
F:GLU468
|
2.5
|
52.5
|
1.0
|
OE2
|
F:GLU465
|
2.7
|
41.5
|
1.0
|
OG1
|
F:THR310
|
2.7
|
52.8
|
1.0
|
CD
|
F:GLU465
|
2.7
|
53.4
|
1.0
|
CB
|
F:THR310
|
3.4
|
47.4
|
1.0
|
C
|
F:THR310
|
3.4
|
49.0
|
1.0
|
C
|
F:PHE313
|
3.6
|
43.0
|
1.0
|
CD
|
F:GLU468
|
3.7
|
57.9
|
1.0
|
O
|
F:ASP307
|
3.9
|
47.1
|
1.0
|
CA
|
F:THR310
|
4.0
|
48.4
|
1.0
|
OG
|
F:SER315
|
4.1
|
36.4
|
1.0
|
N
|
F:PHE313
|
4.2
|
42.5
|
1.0
|
OE2
|
F:GLU468
|
4.2
|
63.7
|
1.0
|
CB
|
F:ASP307
|
4.2
|
50.5
|
1.0
|
CG
|
F:GLU465
|
4.2
|
41.2
|
1.0
|
N
|
F:ASP307
|
4.3
|
55.8
|
1.0
|
CA
|
F:PRO314
|
4.3
|
28.9
|
1.0
|
N
|
F:PRO314
|
4.4
|
44.1
|
1.0
|
N
|
F:SER315
|
4.4
|
37.6
|
1.0
|
N
|
F:PRO311
|
4.4
|
48.5
|
1.0
|
CA
|
F:PHE313
|
4.6
|
44.8
|
1.0
|
C
|
F:PRO314
|
4.6
|
31.7
|
1.0
|
N
|
F:THR310
|
4.6
|
48.5
|
1.0
|
CA
|
F:ASP307
|
4.7
|
50.9
|
1.0
|
CG2
|
F:THR310
|
4.7
|
40.2
|
1.0
|
N
|
F:GLY312
|
4.7
|
47.9
|
1.0
|
C
|
F:ASP307
|
4.7
|
51.4
|
1.0
|
CA
|
F:PRO311
|
4.7
|
43.6
|
1.0
|
CG
|
F:GLU468
|
4.8
|
58.4
|
1.0
|
CA
|
F:GLU465
|
4.9
|
44.0
|
1.0
|
C
|
F:PRO311
|
5.0
|
42.5
|
1.0
|
|
Calcium binding site 3 out
of 3 in 1de4
Go back to
Calcium Binding Sites List in 1de4
Calcium binding site 3 out
of 3 in the Hemochromatosis Protein Hfe Complexed with Transferrin Receptor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Hemochromatosis Protein Hfe Complexed with Transferrin Receptor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Ca803
b:32.9
occ:1.00
|
O
|
I:PHE313
|
2.3
|
33.0
|
1.0
|
OE1
|
I:GLU465
|
2.3
|
21.0
|
1.0
|
OE1
|
I:GLU468
|
2.4
|
37.9
|
1.0
|
O
|
I:THR310
|
2.4
|
46.7
|
1.0
|
OE2
|
I:GLU465
|
2.7
|
35.7
|
1.0
|
OG1
|
I:THR310
|
2.8
|
36.8
|
1.0
|
CD
|
I:GLU465
|
2.9
|
34.7
|
1.0
|
C
|
I:THR310
|
3.4
|
39.9
|
1.0
|
CB
|
I:THR310
|
3.4
|
32.6
|
1.0
|
C
|
I:PHE313
|
3.5
|
32.5
|
1.0
|
CD
|
I:GLU468
|
3.5
|
39.5
|
1.0
|
O
|
I:ASP307
|
4.0
|
33.9
|
1.0
|
CA
|
I:THR310
|
4.0
|
37.6
|
1.0
|
N
|
I:PHE313
|
4.0
|
28.1
|
1.0
|
OE2
|
I:GLU468
|
4.1
|
39.3
|
1.0
|
OG
|
I:SER315
|
4.2
|
27.2
|
1.0
|
CA
|
I:PRO314
|
4.3
|
20.7
|
1.0
|
N
|
I:PRO314
|
4.3
|
31.0
|
1.0
|
N
|
I:ASP307
|
4.4
|
34.7
|
1.0
|
CG
|
I:GLU465
|
4.4
|
28.9
|
1.0
|
N
|
I:PRO311
|
4.4
|
36.9
|
1.0
|
CB
|
I:ASP307
|
4.4
|
32.4
|
1.0
|
CA
|
I:PHE313
|
4.4
|
30.5
|
1.0
|
N
|
I:SER315
|
4.5
|
24.1
|
1.0
|
N
|
I:GLY312
|
4.5
|
32.6
|
1.0
|
C
|
I:PRO314
|
4.6
|
25.2
|
1.0
|
CA
|
I:PRO311
|
4.7
|
36.4
|
1.0
|
N
|
I:THR310
|
4.7
|
38.2
|
1.0
|
CG
|
I:GLU468
|
4.7
|
43.3
|
1.0
|
CG2
|
I:THR310
|
4.8
|
27.5
|
1.0
|
CA
|
I:ASP307
|
4.8
|
31.2
|
1.0
|
C
|
I:ASP307
|
4.8
|
32.2
|
1.0
|
C
|
I:PRO311
|
4.8
|
32.1
|
1.0
|
CA
|
I:GLU465
|
4.9
|
26.1
|
1.0
|
CB
|
I:GLU468
|
4.9
|
25.2
|
1.0
|
|
Reference:
M.J.Bennett,
J.A.Lebron,
P.J.Bjorkman.
Crystal Structure of the Hereditary Haemochromatosis Protein Hfe Complexed with Transferrin Receptor. Nature V. 403 46 2000.
ISSN: ISSN 0028-0836
PubMed: 10638746
DOI: 10.1038/47417
Page generated: Thu Jul 11 07:32:14 2024
|